Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.
about
Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV InfectionA Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal AntibodiesThe effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico.Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearanceNeedle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionEighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmissionMedical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Toward a more accurate estimate of the prevalence of hepatitis C in the United States.Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification.Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study.The role of social networks and geography on risky injection behaviors of young persons who inject drugs.Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients.Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist.Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.Emergency Department Screening for Hepatitis C Virus: Geographic Reach and Spatial Clustering in Central Alabama.Understanding the sepsis mortality belt: time to buckle down!Demographics of Hepatitis C in Southwest Ohio (2010 to 2015).Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012.Treatment utilization among persons with opioid use disorder in the United States.Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.Examining the social context of injection drug use: social proximity vs. geographic proximity to others who inject drugs.Hepatitis C Virus Infection Among Women Giving Birth - Tennessee and United States, 2009-2014.Receipt and timing of HIV drug resistance testing in six U.S. jurisdictions.Down in the valley: Trajectories of injection initiation among young injectors in California's Central Valley.Hepatitis C Treatment and Barriers to Eradication.Opiate Injection-associated Infective Endocarditis in the Southeastern United States.Social context and perspectives of non-medical prescription opioid use among young adults in Rhode Island: A qualitative study.County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.The oncologic burden of hepatitis C virus infection: A clinical perspective.High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
P2860
Q28553005-F0855181-CE6D-44D3-AD69-21ADBA65BB80Q30383939-B137268F-54E2-40B6-B836-F6CA1CCA0C49Q30831694-481BEC58-D19D-4EBB-B64A-314D7B87CCAFQ30842836-1DE8CF5C-BFBB-4654-8D9A-82AA7C161667Q33631104-6A5CAAB2-3ED0-4CE5-80C2-A8D132A66959Q33702754-45F3BEAA-0997-4E26-9537-1B6833F01A8DQ33707925-6C44A654-2706-43E1-BD7C-D240F5D1846CQ33825807-91036225-A4D4-4EE8-AC73-D82290815D5AQ33853664-28B4114B-8E47-4802-A7FB-0B253C47CE26Q34484872-7EF1680A-6F73-4A96-BA20-0143DB3E6BC2Q36290295-3DB033FE-960E-4783-B330-CEA6DE78BC2CQ36433960-DE9DA445-A0E7-45C6-AAEB-E7DE9F946282Q36553043-0231AA93-59EA-44E8-A356-0A5ADD292071Q36701887-9A404E31-6110-47B9-9FA1-2C6221D3C87BQ36783211-2246B542-FA5A-4EDD-BD98-A8C464AF2E8DQ36783216-9B6E16DE-65B1-4F4D-9D52-E56FEEC5894CQ36858878-8A7A4AF0-B699-4D9A-B86B-ABE20B6B2178Q37027342-B0B6E2CB-D52D-4850-AECA-9EFDF5D77AEDQ37075712-EDD0F956-BBAE-45CC-ACD5-96B4085F989BQ37140446-10131742-E713-4B4B-81D0-8FB1F69A5746Q37154709-AEF9FF37-F22B-46CB-8699-C2D17EA5D395Q37220279-718CC942-3E98-4D36-9567-CA9711A384D1Q37227220-6951411B-0281-483D-9F38-F04DB83082F4Q37358965-A0718FA8-2AEA-45FD-9F69-6321B8F96CABQ37466864-900DACE3-BEA5-4296-8FBB-8A43E614BE3DQ38376069-A3B94815-6B3D-420A-A5B2-9BC6E588C283Q38635796-825BF3DF-9F78-41D6-9EE9-1473A9F5A321Q38710078-7BE71A03-6C1E-4223-8EF5-6A3A9EBF2C45Q38719155-DB187F53-B3CF-4CD1-AB56-4CB676863A7AQ38769007-1DE46286-163D-4BD7-B50F-F2228D51C717Q38792091-793B6100-63E9-457B-8C57-0272FC45F786Q38808447-90D81ADE-D7E4-478A-9386-B46CAB8378C7Q38811829-631280C3-E7F0-4B0A-9C5A-0780441FE9ABQ38961563-04F9001D-B173-4029-9EE3-9D3DDEC33E57Q39028794-D0F9FA55-47F3-4AE8-8732-32368C273703Q39041284-10C2337A-E4BB-4163-A904-6D0C7F0D1EE2Q39266916-20EF8206-E2B0-4328-8E19-A2ACC18C26A7Q39418450-6F59FCAF-B242-4052-B1B5-58AAF2994281Q40056569-C2BB56F5-24ED-49E1-8EE5-2058A5ADE9B0Q40083334-51ADFB7A-32CC-404A-8CCB-FEE5E75E6ABB
P2860
Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increases in hepatitis C virus ...... and West Virginia, 2006-2012.
@en
type
label
Increases in hepatitis C virus ...... and West Virginia, 2006-2012.
@en
prefLabel
Increases in hepatitis C virus ...... and West Virginia, 2006-2012.
@en
P2093
P2860
P1476
Increases in hepatitis C virus ...... and West Virginia, 2006-2012.
@en
P2093
Anil Suryaprasad
Deborah Holtzman
Jamie Serrecchia
John W Ward
Jon E Zibbell
Kashif Iqbal
Kathy J Sanders
Loretta Moore-Moravian
Rajiv C Patel
Steven Blankenship
P2860
P304
P577
2015-05-01T00:00:00Z